Dad with Rare Cancer Told He'd Likely Be in Treatment for Life. Then a New Therapy Changed Everything (Exclusive)
Key Points:
- Keaton Herzer was diagnosed with cholangiocarcinoma, a rare and aggressive bile duct cancer, and initially faced limited treatment options with chemotherapy failing to shrink his tumors.
- A newer targeted therapy unexpectedly reduced his tumors, making him eligible for a liver transplant, a rare outcome for patients with this cancer.
- Herzer underwent a liver transplant with his cousin as a living donor, and post-surgery, doctors report no signs of cancer.
- The experience profoundly changed Herzer's outlook on life, emphasizing gratitude and hope for patients with difficult diagnoses.
- Herzer encourages others facing similar challenges to remain hopeful, highlighting the rapid advancements in cancer treatments.